PRISM develop therapeutic drugs that cure these intractable diseases using our unique peptide mimic technology.
PRISM provider of a therapeutic treatment for non-oncology indications.The company develops therapeutic agents that are used to cure pulmonary fibrosis, cancer and incurable diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 13, 2013 | Series C | ¥1.40B | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
CollaboSGK | — | Series C |
Angel Capital | — | Series C |